A retrospective study on disease management in children and adolescents with phenylketonuria during the Covid-19 pandemic lockdown in Austria.
Adherence
Health system resources
Patient self-management
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
19 08 2021
19 08 2021
Historique:
received:
02
07
2021
accepted:
12
08
2021
entrez:
20
8
2021
pubmed:
21
8
2021
medline:
25
8
2021
Statut:
epublish
Résumé
In classical phenylketonuria (PKU) phenylalanine (Phe) accumulates due to functional impairment of the enzyme phenylalanine hydroxylase caused by pathogenic variants in the PAH gene. PKU treatment prevents severe cognitive impairment. Blood Phe concentration is the main biochemical monitoring parameter. Between appointments and venous blood sampling, Austrian PKU patients send dried blood spots (DBS) for Phe measurements to their centre. Coronavirus disease-19 (COVID-19), caused by the SARS CoV-2 virus, was classified as a pandemic by the World Health Organization in March 2020. In Austria, two nationwide lockdowns were installed during the first and second pandemic wave with variable regional and national restrictions in between. This retrospective questionnaire study compared the frequency of Phe measurements and Phe concentrations during lockdown with the respective period of the previous year in children and adolescents with PKU and explored potential influencing factors. 77 patients (30 female, 47 male; mean age 12.4 [8-19] years in 2020) from five centres were included. The decline of venous samples taken on appointments in 2020 did not reach significance but the number of patients with none or only one DBS tripled from 4 (5.2%) in 2019 to 12 (15.6%) in 2020. Significantly more patients had a decline than a rise in the number of DBS sent in between 2019 and 2020 (p < 0.001; Chi During the COVID pandemic, the number of PKU patients who stopped sending DBS to their metabolic centre increased significantly, especially among those older than 16 years. Those who kept up sending DBS maintained stable Phe concentrations. Our follow-up system, which is based on DBS sent in by patients to trigger communication with the metabolic team served adherent patients well. It failed, however, to actively retrieve patients who stopped or reduced Phe measurements.
Sections du résumé
BACKGROUND
In classical phenylketonuria (PKU) phenylalanine (Phe) accumulates due to functional impairment of the enzyme phenylalanine hydroxylase caused by pathogenic variants in the PAH gene. PKU treatment prevents severe cognitive impairment. Blood Phe concentration is the main biochemical monitoring parameter. Between appointments and venous blood sampling, Austrian PKU patients send dried blood spots (DBS) for Phe measurements to their centre. Coronavirus disease-19 (COVID-19), caused by the SARS CoV-2 virus, was classified as a pandemic by the World Health Organization in March 2020. In Austria, two nationwide lockdowns were installed during the first and second pandemic wave with variable regional and national restrictions in between. This retrospective questionnaire study compared the frequency of Phe measurements and Phe concentrations during lockdown with the respective period of the previous year in children and adolescents with PKU and explored potential influencing factors.
RESULTS
77 patients (30 female, 47 male; mean age 12.4 [8-19] years in 2020) from five centres were included. The decline of venous samples taken on appointments in 2020 did not reach significance but the number of patients with none or only one DBS tripled from 4 (5.2%) in 2019 to 12 (15.6%) in 2020. Significantly more patients had a decline than a rise in the number of DBS sent in between 2019 and 2020 (p < 0.001; Chi
CONCLUSION
During the COVID pandemic, the number of PKU patients who stopped sending DBS to their metabolic centre increased significantly, especially among those older than 16 years. Those who kept up sending DBS maintained stable Phe concentrations. Our follow-up system, which is based on DBS sent in by patients to trigger communication with the metabolic team served adherent patients well. It failed, however, to actively retrieve patients who stopped or reduced Phe measurements.
Identifiants
pubmed: 34412683
doi: 10.1186/s13023-021-01996-x
pii: 10.1186/s13023-021-01996-x
pmc: PMC8374407
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
367Informations de copyright
© 2021. The Author(s).
Références
Mol Genet Metab. 2021 Jul;133(3):257-260
pubmed: 34083143
BMC Health Serv Res. 2021 Mar 25;21(1):279
pubmed: 33766026
Paediatr Child Health (Oxford). 2020 Dec;30(12):430-437
pubmed: 32959000
J Med Internet Res. 2021 Apr 6;23(4):e24552
pubmed: 33769945
Eur J Psychotraumatol. 2021 Apr 16;12(1):1901407
pubmed: 33968328
J Pediatr. 2020 Sep;224:190-193
pubmed: 32497546
Mol Genet Metab. 2020 Nov;131(3):285-288
pubmed: 33004274
Genet Med. 2019 Aug;21(8):1851-1867
pubmed: 30546086
Am J Hum Genet. 2008 Jul;83(1):5-17
pubmed: 18538294
Orphanet J Rare Dis. 2020 Jun 30;15(1):171
pubmed: 32605583
Mol Genet Metab Rep. 2021 Jun;27:100759
pubmed: 33907667
Orphanet J Rare Dis. 2017 Oct 12;12(1):162
pubmed: 29025426
Diabetes Res Clin Pract. 2020 Aug;166:108285
pubmed: 32592835
Mol Genet Metab. 2017 Mar;120(3):190-197
pubmed: 28162992
Nutrients. 2021 Feb 28;13(3):
pubmed: 33671057
Genet Med. 2014 Feb;16(2):188-200
pubmed: 24385074
Telemed J E Health. 2021 Mar 12;:
pubmed: 33719565
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584
pubmed: 33623448
Diabetes Obes Metab. 2021 Jul;23(7):1624-1630
pubmed: 33764666
BMJ Open. 2021 Mar 18;11(3):e045813
pubmed: 33737441